Streetbeat News

Stock Prices

SANA

Sana Biotechnology, Inc. (NASDAQ:SANA) shares rose after the FDA cleared its IND application for SC262, a study for patients with relapsed or refractory B-cell malignancies. This clearance follows a previous FDA clearance for SC291 for lupus nephritis and related conditions. The company anticipates presenting data from multiple studies, including SC262, later in the year. SANA's stock price increased by 2.24% to $5.01.

Portfolio Pulse from Nabaparna Bhattacharya

January 05, 2024 | 3:54 pm

Jefferies analyst Brent Thill has upgraded Dynatrace (NYSE:DT) from Hold to Buy and increased the price target from $50 to $70.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:52 pm

BAC

JPM

JPMorgan Chase & Co (JPM) stock hit a new 52-week high of $173.35, reflecting a 25% increase over the past year, largely gained in the last two months. Positive trends and a rising OBV indicator suggest further potential growth. Bank of America Corp. (BAC) Securities sees U.S. banking stocks, especially mega-cap banks, as undervalued with a 50% P/E discount to the S&P 500. Analysts are bullish on JPM with price targets of $188 and $212. JPMorgan's market share growth and operational efficiencies are expected to continue driving its stock value up.

Portfolio Pulse from Surbhi Jain

January 05, 2024 | 3:49 pm

MPW

Medical Properties Trust (MPW) shares dropped following the announcement of its intent to recover uncollected rents and outstanding loan obligations from Steward Health Care System. Additionally, Keybanc downgraded MPW from Overweight to Sector Weight.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:46 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trading levels for SPY, QQQ, AAPL, MSFT, TSLA, GOOGL, META, and NVDA based on a proprietary formula considering price, volume, and options flow. The memo outlines potential bullish and bearish price targets for each asset and advises traders to monitor these stocks closely for breakouts or reversals. The release of the Non-Farm Payrolls report is expected to significantly influence market sentiment and volatility. The memo is part of the Market Clubhouse membership, which offers daily market analysis, a watch list, and real-time trading mentorship by a professional trader known as RIPS.

Portfolio Pulse from RIPS

January 05, 2024 | 3:46 pm

ADSK

Hedge funds and asset managers, including Amundi, D.E. Shaw, and Woodline Partners LP, have increased their holdings in Autodesk Inc. (NASDAQ:ADSK), with D.E. Shaw notably raising their stake by 73.96%. Autodesk reported a 10% YoY increase in Q3 FY24 revenue and raised FY24 guidance. The company is recognized for its 3D design software and operates with high margins and ROE. Management aligns with shareholder interests through share repurchases and performance-based compensation. Autodesk's financial health is solid with a strong cash position and manageable debt. However, a reverse discounted cash flow analysis suggests the current valuation may be high, with a potential 35% downside in share price.

Portfolio Pulse from Quiver Quantitative

January 05, 2024 | 3:41 pm

NVO

A U.S. study found that Novo Nordisk's drugs Ozempic and Wegovy do not increase the risk of suicidal thoughts. Contrary to prior concerns, the study showed a lower incidence of such thoughts among users compared to other treatments. The study, funded by the U.S. National Institutes of Health and published in 'Nature,' analyzed data from over 1.8 million patients. Semaglutide, the active ingredient in both drugs, was linked to a significantly lower risk of suicidal ideations. Novo Nordisk's stock (NVO) was down 0.60% at $106.99 on the last check Friday.

Portfolio Pulse from Vandana Singh

January 05, 2024 | 3:41 pm

DRMA

Dermata Therapeutics Inc (NASDAQ:DRMA) stock rose after announcing a new patent in Japan for its DMT410 program for hyperhidrosis. The patent strengthens the company's IP and could support further development for additional skin conditions. The company's Spongilla technology enables topical delivery of botulinum toxin, avoiding injections. Phase 1 trials of DMT410 with BOTOX showed promising results for hyperhidrosis and aesthetic skin conditions. DRMA shares surged 31% to 80 cents.

Portfolio Pulse from Vandana Singh

January 05, 2024 | 3:40 pm

EDU

PDD

East Buy Holding Ltd., a livestreaming e-commerce subsidiary of New Oriental Education (NYSE:EDU), fired its CEO Sun Dongxu after a dispute with top influencer Dong Yuhui. The company's shares rallied 21.9% following the CEO's removal. East Buy has seen rapid growth since shifting from online tutoring to e-commerce, with a high P/E ratio close to that of PDD Holdings (NASDAQ:PDD). The incident highlights the risks of relying on key influencers in the livestreaming e-commerce industry. Other companies like JD.com (NASDAQ:JD) are exploring virtual hosts to mitigate these risks.

Portfolio Pulse from The Bamboo Works

January 05, 2024 | 3:35 pm

JAMF

Traders are monitoring Jamf Holding Corp. due to circulation of Zacks HomeRun Investor Newsletter which has picked the stock, potentially influencing its trading activity.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:34 pm